NDC 11822-4763

Cold Sore Fever Blister Treatment

Docosanol

Cold Sore Fever Blister Treatment is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Rite Aid Corporation. The primary component is Docosanol.

Product ID11822-4763_86aea66d-abf5-4e99-a18a-b3a0952cd1af
NDC11822-4763
Product TypeHuman Otc Drug
Proprietary NameCold Sore Fever Blister Treatment
Generic NameDocosanol
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2021-12-31
Marketing CategoryANDA /
Application NumberANDA208754
Labeler NameRite Aid Corporation
Substance NameDOCOSANOL
Active Ingredient Strength100 mg/g
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 11822-4763-2

2 TUBE in 1 PACKAGE (11822-4763-2) > 2 g in 1 TUBE
Marketing Start Date2021-12-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cold Sore Fever Blister Treatment" or generic name "Docosanol"

NDCBrand NameGeneric Name
0363-9220Cold Sore Fever Blister TreatmentDocosanol
0363-9222Cold Sore Fever Blister TreatmentDocosanol
11673-846Cold Sore Fever Blister TreatmentDocosanol
11673-926Cold Sore Fever Blister TreatmentDocosanol
11822-0951Cold Sore Fever Blister TreatmentDocosanol
11822-3927Cold Sore Fever Blister TreatmentDocosanol
11822-3951Cold Sore Fever Blister TreatmentDocosanol
11822-3977Cold Sore Fever Blister TreatmentDocosanol
11822-4763Cold Sore Fever Blister TreatmentDocosanol
21130-823Cold Sore Fever Blister TreatmentDocosanol
30142-981Cold Sore Fever Blister TreatmentDocosanol
0135-0200ABREVAdocosanol
0135-0300ABREVAdocosanol
30142-322Cold Sore Fever BlisterDocosanol
0363-2981DocosanolDocosanol
0472-2981DocosanolDocosanol
0591-2981DocosanolDocosanol
21130-422DocosanolDocosanol
21922-023DocosanolDocosanol

© 2023 FDA.report
This site is not affiliated with or endorsed by the FDA.